Lifevantage (LFVN) Common Equity (2011 - 2026)

Lifevantage has reported Common Equity for 16 years, with the latest figure at $33.3 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 1.98% year-over-year to $33.3 million; the trailing twelve-month figure through Mar 2026 stood at $33.3 million (down 1.98% YoY), and the FY2025 full-year result was $34.6 million, up 33.28% from the prior year.
• Common Equity for Q1 2026 stood at $33.3 million, up from $33.0 million in the prior quarter.
• The five-year high for Common Equity was $34.6 million in Q2 2023, with the low at $26.0 million in Q2 2024.
• Historically, Common Equity has averaged $31.3 million across 5 years, with a median of $31.9 million in 2022.
• Annual changes were most pronounced in 2024 — Common Equity slipped 24.99% — and 2025, when it surged 33.28%.
• Lifevantage's Common Equity stood at $31.9 million in 2022, then declined by 14.38% to $27.3 million in 2023, then rose by 9.46% to $29.9 million in 2024, then advanced by 10.37% to $33.0 million in 2025, then increased by 1.07% to $33.3 million in 2026.
• The last three Common Equity figures came in at $33.3 million (Q1 2026), $33.0 million (Q4 2025), and $33.2 million (Q3 2025), per Business Quant data.